Nanodisc-incorporated hemagglutinin provides protective immunity against influenza virus infection

Journal of Virology

Volumn 84, Issue 1, 2010, Pages 361-371

  Bhattacharya, Palash ^a   Grimme, Steve ^b   Ganesh, Balaji ^a   Gopisetty, Anupama ^a   Sheng, Jian Rong ^a   Martinez, Osvaldo ^c   Jayarama, Shankar ^a   Artinger, Michael ^b   Meriggioli, Matthew ^a   Prabhakar, Bellur S ^a  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^b Nanodisc Inc   (United States)

^c MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HEMAGGLUTININ ANTIBODY; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G1; IMMUNOGLOBULIN M; INFLUENZA VACCINE; INFLUENZA VIRUS HEMAGGLUTININ; NANODISC; NANOMATERIAL; RECOMBINANT INFLUENZA VIRUS HEMAGGLUTININ; SCAFFOLD PROTEIN; UNCLASSIFIED DRUG; VIRUS ANTIBODY; VIRUS ENVELOPE PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY RESPONSE; ANTIBODY TITER; ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; HEMAGGLUTINATION INHIBITION TEST; IMMUNE RESPONSE; INFLUENZA; INFLUENZA VACCINATION; INFLUENZA VIRUS A H1N1; LIPID BILAYER; MOUSE; NONHUMAN; PASSIVE IMMUNIZATION; PRIORITY JOURNAL; REPRODUCIBILITY; VIRUS ENVELOPE; VIRUS IMMUNITY; VIRUS STRAIN;

ANIMALS; ANTIBODIES, VIRAL; HEMAGGLUTININ GLYCOPROTEINS, INFLUENZA VIRUS; HUMANS; IMMUNITY, HUMORAL; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA VACCINES; MEMBRANE PROTEINS; MICE; NANOPARTICLES; ORTHOMYXOVIRIDAE INFECTIONS; PHOSPHOLIPIDS;

DISCOIDAE; ORTHOMYXOVIRIDAE;

EID: 72849151959     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.01355-09     Document Type: Article

References (29)

1. Baas, B. J., I. G. Denisov, and S. G. Sligar. 2004. Homotropic cooperativity of monomeric cytochrome P450 3A4 in a nanoscale native bilayer environment. Arch. Biochem. Biophys. 430:218-228.
2. Bayburt, T. H., J. W. Carlson, and S. G. Sligar. 1998. Reconstitution and imaging of a membrane protein in a nanometer-size phospholipid bilayer. J. Struct. Biol. 123:37-44.
3. Bayburt, T. H., and S. G. Sligar. 2003. Self-assembly of single integral membrane proteins into soluble nanoscale phospholipid bilayers. Protein Sci. 12:2476-2481.
4. Bayburt, T. H., and S. G. Sligar. 2002. Single-molecule height measurements on microsomal cytochrome P450 in nanometer-scale phospholipid bilayer disks. Proc. Natl. Acad. Sci. U. S. A. 99:6725-6730.
5. Boldog, T., S. Grimme, M. Li, S. G. Sligar, and G. L. Hazelbauer. 2006. Nanodiscs separate chemoreceptor oligomeric states and reveal their signaling properties. Proc. Natl. Acad. Sci. U. S. A. 103:11509-11514.
6. Bright, R. A., D. M. Carter, S. Daniluk, F. R. Toapanta, A. Ahmad, V. Gavrilov, M. Massare, P. Pushko, N. Mytle, T. Rowe, G. Smith, and T. M. Ross. 2007. Influenza virus-like particles elicit broader immune responses than whole virion inactivated influenza virus or recombinant hemagglutinin. Vaccine 25:3871-3878.
7. Chen, P. S., T. Y. Toribara, and H. Warner. 1956. Microdetermination of phosphorus. Anal. Chem. 28:1756-1758.
8. Civjan, N. R., T. H. Bayburt, M. A. Schuler, and S. G. Sligar. 2003. Direct solubilization of heterologously expressed membrane proteins by incorporation into nanoscale lipid bilayers. Biotechniques 35:556-560, 562-563.
9. Cox, R. J., K. A. Brokstad, and P. Ogra. 2004. Influenza virus: immunity and vaccination strategies. Comparison of the immune response to inactivated and live, attenuated influenza vaccines. Scand. J. Immunol. 59:1-15.
10. Denisov, I. G., B. J. Baas, Y. V. Grinkova, and S. G. Sligar. 2007. Cooperativity in cytochrome P450 3A4: linkages in substrate binding, spin state, uncoupling, and product formation. J. Biol. Chem. 282:7066-7076.
11. Denisov, I. G., Y. V. Grinkova, A. A. Lazarides, and S. G. Sligar. 2004. Directed self-assembly of monodisperse phospholipid bilayer Nanodiscs with controlled size. J. Am. Chem. Soc. 126:3477-3487.
12. Denisov, I. G., M. A. McLean, A. W. Shaw, Y. V. Grinkova, and S. G. Sligar. 2005. Thermotropic phase transition in soluble nanoscale lipid bilayers. J. Phys. Chem. B 109:15580-15588.
13. Duan, H., N. R. Civjan, S. G. Sligar, and M. A. Schuler. 2004. Co-incorporation of heterologously expressed Arabidopsis cytochrome P450 and P450 reductase into soluble nanoscale lipid bilayers. Arch. Biochem. Biophys. 424:141-153.
14. Fiers, W., S. Neirynck, T. Deroo, X. Saelens, and W. M. Jou. 2001. Soluble recombinant influenza vaccines. Philos. Trans. R. Soc. Lond. B Biol. Sci. 356:1961-1963.
15. Gill, S. C., and P. H. von Hippel. 1989. Calculation of protein extinction coefficients from amino acid sequence data. Anal. Biochem. 182:319-326.
16. Hoffmann, E., J. Stech, Y. Guan, R. G. Webster, and D. R. Perez. 2001. Universal primer set for the full-length amplification of all influenza A viruses. Arch. Virol. 146:2275-2289.
17. Leitz, A. J., T. H. Bayburt, A. N. Barnakov, B. A. Springer, and S. G. Sligar. 2006. Functional reconstitution of Beta2-adrenergic receptors utilizing self-assembling Nanodisc technology. Biotechniques 40:601-602, 604, 606.
18. Martinet, W., T. Deroo, X. Saelens, E. Beirnaert, P. Vanlandschoot, R. Contreras, W. Fiers, and W. M. Jou. 1998. Evaluation of recombinant A/Victoria/3/75 (H3N2) influenza neuraminidase mutants as potential broad-spectrum subunit vaccines against influenza A. Arch. Virol. 143:2011-2019.
19. McBurney, S. P., K. R. Young, and T. M. Ross. 2007. Membrane embedded HIV-1 envelope on the surface of a virus-like particle elicits broader immune responses than soluble envelopes. Virology 358:334-346.
20. Nath, A., W. M. Atkins, and S. G. Sligar. 2007. Applications of phospholipid bilayer nanodiscs in the study of membranes and membrane proteins. Biochemistry 46:2059-2069.
21. Plante, M., T. Jones, F. Allard, K. Torossian, J. Gauthier, N. St-Félix, G. L. White, G. H. Lowell, and D. S. Burt. 2001. Nasal immunization with subunit proteosome influenza vaccines induces serum HAI, mucosal IgA and protection against influenza challenge. Vaccine 20:218-225.
22. Reed, L. H., and H. Muench. 1938. A simple method of estimating fifty per cent endpoints. Am. J. Hyg. 27:493-497.
23. Shaw, A. W., M. A. McLean, and S. G. Sligar. 2004. Phospholipid phase transitions in homogeneous nanometer scale bilayer discs. FEBS Lett. 556:260-264.
24. Shaw, A. W., V. S. Pureza, S. G. Sligar, and J. H. Morrissey. 2007. The local phospholipid environment modulates the activation of blood clotting. J. Biol. Chem. 282:6556-6563.
25. Shvartsman, Y. S., and M. P. Zykov. 1976. Secretory anti-influenza immunity. Adv. Immunol. 22:291-330.
26. Suzuki, Y. 2005. Sialobiology of influenza: molecular mechanism of host range variation of influenza viruses. Biol. Pharm. Bull. 28:399-408.
27. Treanor, J. J., G. M. Schiff, F. G. Hayden, R. C. Brady, C. M. Hay, A. L. Meyer, J. Holden-Wiltse, H. Liang, A. Gilbert, and M. Cox. 2007. Safety and immunogenicity of a baculovirus-expressed hemagglutinin influenza vaccine: a randomized controlled trial. JAMA 297:1577-1582.
28. Vanlandschoot, P., G. Maertens, W. M. Jou, and W. Fiers. 1993. Recombinant secreted haemagglutinin protects mice against a lethal challenge of influenza virus. Vaccine 11:1185-1187.
29. Watanabe, I., T. M. Ross, S. Tamura, T. Ichinohe, S. Ito, H. Takahashi, H. Sawa, J. Chiba, T. Kurata, T. Sata, and H. Hasegawa. 2003. Protection against influenza virus infection by intranasal administration of C3d-fused hemagglutinin. Vaccine 21:4532-4538.